Essegas-L Capsule SR is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, formulated to provide effective relief from gastrointestinal disorders. Levosulpiride, a selective dopamine D2 receptor antagonist, enhances gastrointestinal motility and exhibits prokinetic properties, making it beneficial in treating conditions such as functional dyspepsia, gastroesophageal reflux disease (GERD), and delayed gastric emptying. Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, thereby promoting ulcer healing and alleviating symptoms associated with acid-related disorders. The sustained-release formulation of Essegas-L Capsule SR ensures prolonged therapeutic action, improving patient compliance by reducing dosing frequency. This combination is particularly useful in managing symptoms like heartburn, epigastric pain, nausea, and bloating, often seen in GERD and functional dyspepsia. It is advisable to take this medication under medical supervision, especially in patients with a history of hypersensitivity to either component, liver or kidney impairment, or concurrent use of other medications that may interact. Common side effects may include headache, dizziness, dry mouth, or mild gastrointestinal disturbances. Essegas-L Capsule SR offers a comprehensive approach to managing complex gastrointestinal conditions by addressing both motility and acid secretion abnormalities.